Navigation Links
Ethicon Endo-Surgery to Acquire SurgRx
Date:8/11/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
(Date:11/5/2009)...vember 5, 2009 Senomyx, ...proprietary taste receptor-based technologies to d...erage, and ingredient supply industries, today pro...sults for the third quarter ended September 30, 20...ter of 2009, compared to $4.0 million for the thir...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...ETHESDA, Md., Feb. 29 Micromet, Inc.,(Nasdaq: MI..., proprietary,antibodies for the treatment of canc...nounced that Dr. Christian Itin, President and Chi...the Susquehanna Financial,Group,s SIGnificant Inve..., at 10:30 am ET at the W Hotel in New York., Dr....
...UEBEC CITY, Feb. 29 /PRNewswire-FirstCall/ - AEter...bal biopharmaceutical company focused on,endocrine...tion of Mario,Paradis, CA, the Company,s Senior Vi...orporate Secretary. Mr. Paradis has accepted the p...cer of Atrium Innovations, a leading,developer, ma...
...RVINE, Calif., Feb. 29 NuRx Pharmaceuticals,Inc. ...retained Russo,Partners LLC for the provision of i...nsel., The healthcare communications firm will im...nvestor targeting, the scheduling of,presentations...r corporate,visibility initiatives. Russo Partners...
Other Biology Technology:Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008 2AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs 2NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel 2NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel 3
(Date:11/4/2009)...deciphered the DNA codes, or genomes, of the famed...ed The Genome 10K Project, an international effort...s on 10,000 species of animals for conducting comp...be achieved. , Participating in The Genome 10K p... 5, 2009 issue of the Journal of Heredity , are 7...
(Date:11/4/2009)...Newswire-FirstCall/ -- Quest Diagnostics Incorpora... diagnostic testing, information and services, ann...30, 2009, income from continuing operations rose t...160 million, or $0.81 per diluted share, for the t...ts were reduced by a $0.03 per share charge associ...
(Date:11/4/2009)...wswire/ -- What,s the cost of saving a teenage lif...sulting from prescription medication abuse, there,...ver, may be unaware that the lock-boxes they,ve in...cking timebomb of prescription drugs. That,s why M...dical supplies, has formed an exclusive partnershi...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Single Parents May Do as Well as Two 3A Study 56314 1Single Parents May Do as Well as Two 3A Study 56314 2TrueShred Earns Industrys Highest Security Certification 56311 1As August Congressional Recess Concludes Polls Show Seniors General Public Strongly Opposed to Medicare Cuts in Congressional Health Reform Plan Sa 56309 1As August Congressional Recess Concludes Polls Show Seniors General Public Strongly Opposed to Medicare Cuts in Congressional Health Reform Plan Sa 56309 2As August Congressional Recess Concludes Polls Show Seniors General Public Strongly Opposed to Medicare Cuts in Congressional Health Reform Plan Sa 56309 3
...008 Two new articles examine the theory of "fetal...sparities. The studies, published in American Jou...tes of hypertension and cardiovascular disease pre...low birth weights, and that these low birth weight...ctors. , It is well-established that the nutritio...
...e sang with the croaks, chirps and ribbits of doze...ms of a fungus that,s decimating amphibian populat... been documented for more than a decade, but until...s of frogs alters the larger ecosystem. A Universi...sively examine an ecosystem before and after an am...
...ssouri Department of Psychological Sciences introd...he opening of the Brain Imaging Center (BIC). The ...l research on diseases that can have tremendous im...ophrenia and other neurocognitive disorders using ...he Brain Imaging Center is a state-of-the-art neur...
Other Biology News:Racial disparities in cardiovascular health linked to birth weight, slavery 2Racial disparities in cardiovascular health linked to birth weight, slavery 3UGA study reveals ecosystem-level consequences of frog extinctions 2UGA study reveals ecosystem-level consequences of frog extinctions 3MU brain imaging center provides research for autism, schizophrenia and Parkinson's disease 2
Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience
Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam
Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Biology Products: